SCHEMBL10048773

SCHEMBL10048773

O=C(CNc1c(-c2ccc(OC(F)(F)F)cc2)nc2cnccn12)N1CCNCC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.51
GAA P10253 5/20 0.51
KDM4E B2RXH2 4/20 0.51
HPGD P15428 2/20 0.51
CASP1 P29466 2/20 0.51
CASP7 P55210 2/20 0.51
HSD17B10 Q99714 2/20 0.51
ALOX15 P16050 1/20 0.51
BRD4 O60885 2/20 0.45
ATM Q13315 7/20 0.43
TLR9 Q9NR96 3/20 0.42
APAF1 O14727 1/20 0.42
MAPT P10636 3/20 0.42
LMNA P02545 1/20 0.42
TUBB4A P04350 2/20 0.41
TUBB P07437 2/20 0.41
TUBA3C P0DPH7 2/20 0.41
TUBA1B P68363 2/20 0.41
TUBA4A P68366 2/20 0.41
TUBB4B P68371 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14963812 0.90 ALDH1A1 (0.53) ALDH1A1GAAKDM4EHPGDCASP1
SCHEMBL14963815 0.90 ALDH1A1 (0.53) ALDH1A1GAAKDM4EHPGDCASP1
SCHEMBL10048699 0.87 GAA (0.49) ALDH1A1GAAKDM4EHPGDCASP1
SCHEMBL14963863 0.86 KDM4E (0.47) ALDH1A1GAAKDM4EHPGDCASP1
SCHEMBL14963862 0.86 ALDH1A1 (0.47) ALDH1A1GAAKDM4EHPGDCASP1
SCHEMBL10048609 0.85 CDK9 (0.53) ALDH1A1GAAKDM4EHPGDCASP1
SCHEMBL10048727 0.85 KDM4E (0.49) ALDH1A1GAAKDM4EHPGDCASP1
SCHEMBL14963837 0.85 KDM4E (0.51) ALDH1A1GAAKDM4EHPGDCASP1
SCHEMBL10048765 0.85 KDM4E (0.47) ALDH1A1GAAKDM4EHPGDCASP1
SCHEMBL14963835 0.85 NAMPT (0.49) ALDH1A1GAAKDM4EHPGDCASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012018665-A1 FUSED-IMIDAZOYL COMPOUNDS USEFUL AS ANTIMICROBIAL AGENTS SCHERING CORPORATION (US) 2012-02-09 WO disclosed